Professor Charles F Gilks FRCP

Publications


Journals

  • Lara AM; Wakholi BN; Kasirye A; Munderi P; Watera C; Lalloo DG; Haycox A; Gilks CF; et alGrosskurth H. (Jul 2008). Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans. AIDS. 22:S123-S130.
  • Phillips AN; Pillay D; Miners A; Gilks CF; Lundgren JD. (Jul 2008). Monitoring of antiretroviral therapy in low-resource settings - Reply. LANCET. 372:289-289.
  • Reid A; Stoehr W; Walker AS; Williams IG; Kityo C; Hughes P; Kambugu A; Gilks CF; et alMugyenyi P; Munderi P; Hakim J; Gibb DM; Dev Antiretroviral Therapy Trial. (15 Apr 2008). Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. CLIN INFECT DIS. 46:1271-1281. DOI.
  • Phillips AN; Pillay D; Miners AH; Bennett DE; Gilks CF; Lundgren JD. (Apr 2008). Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. LANCET. 371:1443-1451.
  • Bennett DE; Myatt M; Bertagnolio S; Sutherland D; Gilks CF. (2008). Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. ANTIVIR THER. 13:25-36.
  • Bennett DE; Bertagnolio S; Sutherland D; Gilks CF. (2008). The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther. 13 Suppl 2:1-13.
  • Taegtmeyer M; Suckling RM; Nguku PM; Meredith C; Kibaru J; Chakaya JM; Muchela H; Gilks CF. (2008). Working with risk: Occupational safety issues among healthcare workers in Kenya. AIDS CARE. 20:304-310. DOI.
  • Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D. (2008). World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites. Antivir Ther. 13 Suppl 2:15-23.
  • Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; et alMorris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P. (2008). World Health Organization/HIVResNet Drug Resistance Laboratory Strategy. Antivir Ther. 13 Suppl 2:49-57.
  • Arthur G; Nduba V; Forsythe S; Mutemi R; Odhiambo J; Gilks C. (Dec 2007). Behaviour change in clients of health centre-based voluntary HIV counselling and testing services in Kenya. Sex Transm Infect. 83:541-546. DOI.
  • Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N. (Sep 2007). International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Am J Obstet Gynecol. 197:S42-S55. DOI.
  • Suckling RM; Taegtmeyer M; Nguku PM; Al-Abri SS; Kibaru J; Chakaya JM; Tukei PM; Gilks CF. (Nov 2006). Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake. J Hosp Infect. 64:271-277. DOI.
  • Cooke GS; Tosh K; Ramaley PA; Kaleebu P; Zhuang J; Nakiyingi JS; Watera C; Gilks CF; et alFrench N; Whitworth JA; Hill AV. (1 Sep 2006). A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease. J Infect Dis. 194:666-669. DOI.
  • Gilks CF; Crowley S; Ekpini R; Gove S; Perriens J; Souteyrand Y; Sutherland D; Vitoria M; et alGuerma T; De Cock K. (5 Aug 2006). The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 368:505-510. DOI.
  • Beck EJ; Vitoria M; Mandalia S; Crowley S; Gilks CF; Souteyrand Y. (13 Jul 2006). National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?. AIDS. 20:1497-1502. DOI.
  • Ssali F; Stohr W; Munderi P; Reid A; Walker AS; Gibb DM; Mugyenyi P; Kityo C; et alGrosskurth H; Hakim J; Byakwaga H; Katabira E; Darbyshire JH; Gilks CF; DART Trial Team. (2006). Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. ANTIVIR THER. 11:741-749.
  • Miiro G; Kayhty H; Watera C; Tolmie H; Whitworth JA; Gilks CF; French N. (15 Nov 2005). Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine. J Infect Dis. 192:1801-1805. DOI.
  • Arthur GR; Ngatia G; Rachier C; Mutemi R; Odhiambo J; Gilks CF. (1 Nov 2005). The role for government health centers in provision of same-day voluntary HIV counseling and testing in Kenya. J Acquir Immune Defic Syndr. 40:329-335.
  • Korenromp EL; Williams BG; de Vlas SJ; Gouws E; Gilks CF; Ghys PD; Nahlen BL. (Sep 2005). Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. Emerg Infect Dis. 11:1410-1419.
  • Reid A; Dedicoat M; Lalloo D; Gilks CF. (1 Sep 2005). Trends in adult medical admissions in a rural South African hospital between 1991 and 2002. J Acquir Immune Defic Syndr. 40:53-56.
  • Grimwade K; Sturm AW; Nunn AJ; Mbatha D; Zungu D; Gilks CF. (28 Jan 2005). Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa. AIDS. 19:163-168.
  • Elliott AM; Hodsdon WS; Kyosiimire J; Quigley MA; Nakiyingi JS; Namujju PB; Watera C; French N; et alGilks CF; Dockrell HM; Whitworth JA. (Nov 2004). Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans R Soc Trop Med Hyg. 98:660-670. DOI.
  • Dedicoat M; Newton R; Alkharsah KR; Sheldon J; Szabados I; Ndlovu B; Page T; Casabonne D; et alGilks CF; Cassol SA; Whitby D; Schulz TF. (15 Sep 2004). Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis. 190:1068-1075. DOI.
  • French N; Moore M; Haikala R; Kayhty H; Gilks CF. (15 Aug 2004). A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults. J Infect Dis. 190:707-712. DOI.
  • Watera C; Nakiyingi J; Miiro G; Muwonge R; Whitworth JA; Gilks CF; French N. (21 May 2004). 23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort. AIDS. 18:1210-1213.
  • Grimwade K; French N; Mbatha DD; Zungu DD; Dedicoat M; Gilks CF. (20 Feb 2004). HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS. 18:547-554.
  • Grimwade K; French N; Mbatha DD; Zungu DD; Dedicoat M; Gilks CF. (Dec 2003). Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr Infect Dis J. 22:1057-1063. DOI.
  • Dedicoat M; Grimwade K; Newton R; Gilks C. (Oct 2003). Changes in the patient population attending a primary health care clinic in rural South Africa between 1991 and 2001. S Afr Med J. 93:777-778.
  • Elliott AM; Kyosiimire J; Quigley MA; Nakiyingi J; Watera C; Brown M; Joseph S; French N; et alGilks CF; Whitworth JA. (Jul 2003). Eosinophilia and progression to active tuberculosis in HIV-1-infected Ugandans. Trans R Soc Trop Med Hyg. 97:477-480.
  • Mundy CJ; Bates I; Nkhoma W; Floyd K; Kadewele G; Ngwira M; Khuwi A; Squire SB; et alGilks CF. (Jul 2003). The operation, quality and costs of a district hospital laboratory service in Malawi. Trans R Soc Trop Med Hyg. 97:403-408.
  • French N; Williams G; Williamson V; Bhatt SM; Gilks CF. (18 Oct 2002). The radiographic appearance of pneumococcal pneumonia in adults is unaltered by HIV-1-infection in hospitalized Kenyans. AIDS. 16:2095-2096.
  • Gordon MA; Banda HT; Gondwe M; Gordon SB; Boeree MJ; Walsh AL; Corkill JE; Hart CA; et alGilks CF; Molyneux ME. (16 Aug 2002). Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS. 16:1633-1641.
  • Brink AK; Mahé C; Watera C; Lugada E; Gilks C; Whitworth J; French N. (Aug 2002). Diarrhea, CD4 counts and enteric infections in a community-based cohort of HIV-infected adults in Uganda. J Infect. 45:99-106.
  • Gordon SB; Chaponda M; Walsh AL; Whitty CJ; Gordon MA; Machili CE; Gilks CF; Boeree MJ; et alKampondeni S; Read RC; Molyneux ME. (5 Jul 2002). Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS. 16:1409-1417.
  • Kariuki S; Gilks C; Kimari J; Muyodi J; Getty B; Hart CA. (Jul 2002). Carriage of potentially pathogenic Escherichia coli in chickens. Avian Dis. 46:721-724.
  • Forsythe S; Arthur G; Ngatia G; Mutemi R; Odhiambo J; Gilks C. (Jun 2002). Assessing the cost and willingness to pay for voluntary HIV counselling and testing in Kenya. Health Policy Plan. 17:187-195.
  • Ramaley PA; French N; Kaleebu P; Gilks C; Whitworth J; Hill AV. (9 May 2002). HIV in Africa (Communication arising): chemokine-receptor genes and AIDS risk. Nature. 417:140. DOI.
  • French N; Gray K; Watera C; Nakiyingi J; Lugada E; Moore M; Lalloo D; Whitworth JA; et alGilks CF. (3 May 2002). Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 16:1031-1038.
  • Kaleebu P; French N; Mahe C; Yirrell D; Watera C; Lyagoba F; Nakiyingi J; Rutebemberwa A; et alMorgan D; Weber J; Gilks C; Whitworth J. (1 May 2002). Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis. 185:1244-1250. DOI.
  • Guinness L; Arthur G; Bhatt SM; Achiya G; Kariuki S; Gilks CF. (12 Apr 2002). Costs of hospital care for HIV-positive and HIV-negative patients at Kenyatta National Hospital, Nairobi, Kenya. AIDS. 16:901-908.
  • Lugada ES; Watera C; Nakiyingi J; Elliott A; Brink A; Nanyunja M; French N; Antivelink L; et alGilks C; Whitworth J. (Apr 2002). Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda. Int J Tuberc Lung Dis. 6:326-331.
  • Spoulou V; Gilks CF; Ioannidis JPA. (30 Mar 2002). Protein conjugate pneumococcal vaccines - Offer new opportunities for high risk individuals but still lack robust evidence. BRIT MED J. 324:750-751.
  • Spoulou V; Gilks CF; Ioannidis JP. (30 Mar 2002). Protein conjugate pneumococcal vaccines. BMJ. 324:750-751.
  • Dowling JJ; Whitty CJ; Chaponda M; Munthali C; Zijlstra EE; Gilks CF; Squire SB; Gordon MA. (Mar 2002). Are intestinal helminths a risk factor for non-typhoidal Salmonella bacteraemia in adults in Africa who are seropositive for HIV? A case-control study. Ann Trop Med Parasitol. 96:203-208. DOI.
  • Tchilian EZ; Dawes R; Ramaley PA; Whitworth JA; Yuldasheva N; Wells RS; Watera C; French N; et alGilks CF; Kunachiwa W; Ruzibakiev R; Leetrakool N; Carrington CV; Ramdath DD; Gotch F; Stephens HA; Hill AV; Beverley PC. (Feb 2002). A CD45 polymorphism associated with abnormal splicing is absent in African populations. Immunogenetics. 53:980-983. DOI.
  • Mundy CJ; Harries AD; Banerjee A; Salaniponi FM; Gilks CF; Squire SB. (Jan 2002). Quality assessment of sputum transportation, smear preparation and AFB microscopy in a rural district in Malawi. Int J Tuberc Lung Dis. 6:47-54.
  • Arthur G; Nduba VN; Kariuki SM; Kimari J; Bhatt SM; Gilks CF. (15 Jul 2001). Trends in bloodstream infections among human immunodeficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade. Clin Infect Dis. 33:248-256. DOI.
  • French N; Nakiyingi J; Lugada E; Watera C; Whitworth JA; Gilks CF. (4 May 2001). Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS. 15:899-906.
  • Gilks CF. (2001). HIV care in non-industrialised countries. Br Med Bull. 58:171-186.
  • Graham SM; Coulter JB; Gilks CF. (Jan 2001). Pulmonary disease in HIV-infected African children. Int J Tuberc Lung Dis. 5:12-23.
  • Gray KJ; French N; Lugada E; Watera C; Gilks CF. (Nov 2000). Rhodococcus equi and HIV-1 infection in Uganda. J Infect. 41:227-231. DOI.
  • French N; Gilks CF. (7 Oct 2000). Pneumococcal vaccine and HIV-1 infection - Reply. LANCET. 356:1272-1273.
  • Mundy C; Ngwira M; Kadewele G; Bates I; Squire SB; Gilks CF. (Sep 2000). Evaluation of microscope condition in Malawi. Trans R Soc Trop Med Hyg. 94:583-584.
  • Wilkinson D; Floyd K; Gilks CF. (Aug 2000). National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa. S Afr Med J. 90:794-798.
  • Arthur G; Bhatt SM; Muhindi D; Achiya GA; Kariuki SM; Gilks CF. (28 Jul 2000). The changing impact of HIV/AIDS on Kenyatta National Hospital, Nairobi from 1988/89 through 1992 to 1997. AIDS. 14:1625-1631.
  • French N; Nakiyingi J; Carpenter LM; Lugada E; Watera C; Moi K; Moore M; Antvelink D; et alMulder D; Janoff EN; Whitworth J; Gilks CF. (17 Jun 2000). 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet. 355:2106-2111.
  • Wilkinson D; Newman W; Reid A; Squire SB; Sturm AW; Gilks CF. (Jun 2000). Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence. Int J Tuberc Lung Dis. 4:513-518.
  • French N; Gilks CF. (May 2000). Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 18 March 1999. Fresh from the field: some controversies in tropical medicine and hygiene. HIV and malaria, do they interact?. Trans R Soc Trop Med Hyg. 94:233-237.
  • Yeung S; Wilkinson D; Escott S; Gilks CF. (Apr 2000). Paediatric HIV infection in a rural South African district hospital. J Trop Pediatr. 46:107-110.
  • French N; Mujugira A; Nakiyingi J; Mulder D; Janoff EN; Gilks CF. (15 Dec 1999). Immunologic and clinical stages in HIV-1-infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease. J Acquir Immune Defic Syndr. 22:509-516.
  • Elliott AM; Nakiyingi J; Quigley MA; French N; Gilks CF; Whitworth JA. (18 Sep 1999). Inverse association between BCG immunisation and intestinal nematode infestation among HIV-1-positive individuals in Uganda. Lancet. 354:1000-1001. DOI.
  • Floyd K; Reid RA; Wilkinson D; Gilks CF. (15 Sep 1999). Admission trends in a rural South African hospital during the early years of the HIV epidemic. JAMA. 282:1087-1091.
  • Wilkinson D; Sheldon J; Gilks CF; Schulz TF. (May 1999). Prevalence of infection with human herpesvirus 8/Kaposi's sarcoma herpesvirus in rural South Africa. S Afr Med J. 89:554-557.
  • Gilks CF. (Mar 1999). The challenge of HIV/AIDS in Sub-Saharan Africa. J R Coll Physicians Lond. 33:180-184.
  • Gilks CF. (30 Jan 1999). Textbook of clinical medicine for asia . BMJ. 318:337A.
  • Gordon SB; Gilks CF. (Jan 1999). Pneumococcal disease in sub-Saharan Africa: could currently available vaccines avert a crisis?. Trop Doct. 29:5-7.
  • Wilkinson D; Floyd K; Gilks CF. (10 Sep 1998). Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity. AIDS. 12:1675-1682.
  • French N; Gilks CF; Mujugira A; Fasching C; O'Brien J; Janoff EN. (10 Sep 1998). Pneumococcal vaccination in HIV-1-infected adults in Uganda: humoral response and two vaccine failures. AIDS. 12:1683-1689.
  • Wilkinson D; Gilks CF. (Sep 1998). Increasing frequency of tuberculosis among staff in a South African district hospital: impact of the HIV epidemic on the supply side of health care. Trans R Soc Trop Med Hyg. 92:500-502.
  • Mwachari C; Batchelor BI; Paul J; Waiyaki PG; Gilks CF. (Jul 1998). Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya. J Infect. 37:48-53.
  • Gilks CF; Floyd K; Otieno LS; Adam AM; Bhatt SM; Warrell DA. (1 Jul 1998). Some effects of the rising case load of adult HIV-related disease on a hospital in Nairobi. J Acquir Immune Defic Syndr Hum Retrovirol. 18:234-240.
  • Gilks CF; Wilkinson D. (11 Apr 1998). Reducing the risk of nosocomial HIV infection in British health workers working overseas: role of post-exposure prophylaxis. BMJ. 316:1158-1160.
  • Gilks CF. (1998). Acute bacterial infections and HIV disease. Br Med Bull. 54:383-393.
  • Gilks CF. (Dec 1997). Improving HIV/AIDS disease surveillance in low-income countries. AIDS. 11:1881-1882.
  • Gilks CF. (Nov 1997). Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 12 December 1996. HIV and pneumococcal infection in Africa. Clinical, epidemiological and preventative aspects. Trans R Soc Trop Med Hyg. 91:627-631.
  • Hawken MP; Meme HK; Elliott LC; Chakaya JM; Morris JS; Githui WA; Juma ES; Odhiambo JA; et alThiong'o LN; Kimari JN; Ngugi EN; Bwayo JJ; Gilks CF; Plummer FA; Porter JD; Nunn PP; McAdam KP. (Jun 1997). Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. AIDS. 11:875-882.
  • Gilks CF; Godfrey-Faussett P; Batchelor BI; Ojoo JC; Ojoo SJ; Brindle RJ; Paul J; Kimari J; et alBruce MC; Bwayo J; Plummer FA; Warrell DA. (Jun 1997). Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya. AIDS. 11:911-918.
  • Gilks CF. (Jun 1997). Tropical medicine in the HIV/AIDS era. LANCET. 349:17-18.
  • Wilkinson D; Floyd K; Gilks CF. (Apr 1997). Costs and cost-effectiveness of alternative tuberculosis management strategies in South Africa--implications for policy. S Afr Med J. 87:451-455.
  • Janoff EN; Fasching C; Ojoo JC; O'Brien J; Gilks CF. (Apr 1997). Responsiveness of human immunodeficiency virus type 1-infected Kenyan women with or without prior pneumococcal disease to pneumococcal vaccine. J Infect Dis. 175:975-978.
  • Marsh BJ; von Reyn CF; Edwards J; Ristola MA; Bartholomew C; Brindle RJ; Gilks CF; Waddell R; et alTosteson AN; Pelz R; Sox CH; Frothingham R; Arbeit RD. (Apr 1997). The risks and benefits of childhood bacille Calmette-Guérin immunization among adults with AIDS. International MAC study groups. AIDS. 11:669-672.
  • Kariuki S; Gilks CF; Kimari J; Muyodi J; Waiyaki P; Hart CA. (Jan 1997). Plasmid diversity of multi-drug-resistant Escherichia coli isolated from children with diarrhoea in a poultry-farming area in Kenya. Ann Trop Med Parasitol. 91:87-94.
  • Gilks CF; Balbirnie E. (Jan 1997). Testing sputum samples for HIV antibodies, using a rapid, saliva-card test system. Ann Trop Med Parasitol. 91:115-117.
  • Gilks CF; Katabira E; De Cock KM. (1997). The challenge of providing effective care for HIV/AIDS in Africa. AIDS. 11 Suppl B:S99-106.
  • Gilks CF. (6 Nov 1996). AIDS in Africa. Br J Hosp Med. 56:442-443.
  • Kariuki S; Muthotho N; Kimari J; Waiyaki P; Hart CA; Gilks CF. (Nov 1996). Molecular typing of multi-drug resistant Shigella dysenteriae type 1 by plasmid analysis and pulsed-field gel electrophoresis. Trans R Soc Trop Med Hyg. 90:712-714.
  • Hawken MP; Ojoo JC; Morris JS; Kariuki EW; Githui WA; Juma ES; Gathua SN; Kimari JN; et alThiong'o LN; Raynes JG; Broadbent P; Gilks CF; Otieno LS; McAdam KP. (Oct 1996). No increased prevalence of adrenocortical insufficiency in human immunodeficiency virus-associated tuberculosis. Tuber Lung Dis. 77:444-448.
  • Gilks CF; Haran D; Wilkinson D. (Sep 1996). Coping with the impact of the HIV epidemic--the Hlabisa-Liverpool HIV link. S Afr Med J. 86:1077-1078.
  • vonReyn CF; Arbeit RD; Tosteson ANA; Ristola MA; Barber TW; Waddell R; Sox CH; Brindle RJ; et alGilks CF; Ranki A; Bartholomew C; Edwards J; Falkinham JO; OConnor GT; Jacobs NJ; Maslow J; Lahdevirta J; Buhler S; Ruohonen R; Lumio J; Vuento R; Prabhakar P; Magnusson M. (Aug 1996). The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. AIDS. 10:1025-1032.
  • Fordham von Reyn C; Arbeit RD; Tosteson AN; Ristola MA; Barber TW; Waddell R; Sox CH; Brindle RJ; et alGilks CF; Ranki A; Bartholomew C; Edwards J; Falkinham JO; O'Connor GT. (Aug 1996). The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group. AIDS. 10:1025-1032.
  • Wilkinson D; Gilks CF. (23 Mar 1996). Lessons to be learned from tuberculosis control in China. LANCET. 347:835-835.
  • Gilks CF; Ojoo SA; Ojoo JC; Brindle RJ; Paul J; Batchelor BI; Kimari JN; Newnham R; et alBwayo J; Plummer FA. (16 Mar 1996). Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet. 347:718-723.
  • Watkins WM; Mungai M; Muhia DK; Mberu EK; Gathua S; Winstanley PA; Gilks CF; Nunn P. (Feb 1996). Cutaneous hypersensitivity reactions to thiacetazone, HIV infection and thiacetazone concentrations in plasma. Br J Clin Pharmacol. 41:160-162.
  • Amdahl BM; Rubins JB; Daley CL; Gilks CF; Hopewell PC; Janoff EN. (Dec 1995). Impaired natural immunity to pneumolysin during human immunodeficiency virus infection in the United States and Africa. Am J Respir Crit Care Med. 152:2000-2004.
  • Paul J; Kimari J; Gilks CF. (14 Oct 1995). Streptococcus pneumoniae resistant to penicillin and tetracycline associated with HIV seropositivity. Lancet. 346:1034-1035.
  • GILKS CF; HARAN D. (15 Jul 1995). IMPACT OF HIV IN SUB-SAHARAN AFRICA. LANCET. 346:187-187.
  • Gilks CF; Haran D. (15 Jul 1995). Impact of HIV in sub-Saharan Africa. Lancet. 346:187.
  • Maslow JN; Whittam TS; Gilks CF; Wilson RA; Mulligan ME; Adams KS; Arbeit RD. (Jul 1995). Clonal relationships among bloodstream isolates of Escherichia coli. Infect Immun. 63:2409-2417.
  • Gilks CF; Brindle RJ; Mwachari C; Batchelor B; Bwayo J; Kimari J; Arbeit RD; von Reyn CF. (1 Feb 1995). Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya. J Acquir Immune Defic Syndr Hum Retrovirol. 8:195-198.
  • Lewis DJ; Gilks CF; Ojoo S; Castello-Branco LR; Dougan G; Evans MR; McDermott S; Griffin GE. (Jun 1994). Immune response following oral administration of cholera toxin B subunit to HIV-1-infected UK and Kenyan subjects. AIDS. 8:779-785.
  • von Reyn CF; Barber TW; Arbeit RD; Sox CH; O'Connor GT; Brindle RJ; Gilks CF; Hakkarainen K; et alRanki A; Bartholomew C. (Dec 1993). Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J Infect Dis. 168:1553-1558.
  • von Reyn CF; Waddell RD; Eaton T; Arbeit RD; Maslow JN; Barber TW; Brindle RJ; Gilks CF; et alLumio J; Lähdevirta J. (Dec 1993). Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J Clin Microbiol. 31:3227-3230.
  • Gilks CF. (23 Oct 1993). The clinical challenge of the HIV epidemic in the developing world. Lancet. 342:1037-1039.
  • Gilks CF. (Jul 1993). HIV disease in Africa. Rev Soc Bras Med Trop. 26:135-139.
  • Temmerman M; Gilks CF; Sanghri HC. (May 1993). Spontaneous and induced abortions at Kenyatta National Hospital, Nairobi, Kenya. Int J Gynaecol Obstet. 41:182-183.
  • Gilks CF. (1 Mar 1993). Pneumococcal disease and HIV infection. Ann Intern Med. 118:393.
  • GILKS CF. (1 Mar 1993). PNEUMOCOCCAL DISEASE AND HIV-INFECTION. ANN INTERN MED. 118:393-393.
  • Gilks CF. (Feb 1993). Prophylaxis for HIV-associated infections in the developing world. J Antimicrob Chemother. 31 Suppl B:119-128.
  • Gilks CF. (28 Nov 1992). Breast feeding and HIV infection. BMJ. 305:1367.
  • GILKS CF. (28 Nov 1992). BREAST-FEEDING AND HIV-INFECTION. BRIT MED J. 305:1367-1367.
  • GILKS CF. (21 Mar 1992). TUBERCULOSIS IN PERSPECTIVE. LANCET. 339:748-748.
  • Gilks CF. (21 Mar 1992). Tuberculosis in perspective. Lancet. 339:748.
  • Gilks CF; Otieno LS; Brindle RJ; Newnham RS; Lule GN; Were JB; Simani PM; Bhatt SM; et alOkelo GB; Waiyaki PG. (Jan 1992). The presentation and outcome of HIV-related disease in Nairobi. Q J Med. 82:25-32.
  • Gilks CF. (9 Nov 1991). What use is a clinical case definition for AIDS in Africa?. BMJ. 303:1189-1190.
  • Gilks CF; Ojoo SA. (Jul 1991). A practical approach to the clinical problems of the HIV-infected adult in the tropics. Trop Doct. 21:90-97.
  • Gilks CF; Ojoo SA; Brindle RJ. (1991). Non-opportunistic bacterial infections in HIV-seropositive adults in Nairobi, Kenya. AIDS. 5 Suppl 1:S113-S116.
  • GILKS CF; OJOO SA; BRINDLE RJ. (1991). NON-OPPORTUNISTIC BACTERIAL-INFECTIONS IN HIV-SEROPOSITIVE ADULTS IN NAIROBI, KENYA. AIDS. 5:S113-S116.
  • Gilks CF; Brindle RJ; Otieno LS; Bhatt SM; Newnham RS; Simani PM; Lule GN; Okelo GB; et alWatkins WM; Waiyaki PG. (Oct 1990). Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. AIDS. 4:981-985.
  • Gilks CF; Brindle RJ; Otieno LS; Simani PM; Newnham RS; Bhatt SM; Lule GN; Okelo GB; et alWatkins WM; Waiyaki PG. (1 Sep 1990). Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet. 336:545-549.
  • Gilks CF; Walliker D; Newbold CI. (Jan 1990). Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi--a rodent malaria model. Parasite Immunol. 12:45-64.
  • GILKS CF; JARRA W; HARVEYWOOD K; MCLEAN SA; SCHETTERS T. (Apr 1989). HOST DIET IN EXPERIMENTAL RODENT MALARIA - A VARIABLE WHICH CAN COMPROMISE EXPERIMENTAL-DESIGN AND INTERPRETATION. PARASITOLOGY. 98:175-177.
  • Gilks CF; Jarra W; Harvey-Wood K; McLean SA; Schetters T. (Apr 1989). Host diet in experimental rodent malaria: a variable which can compromise experimental design and interpretation. Parasitology. 98 Pt 2:175-177.
  • Gilks CF; Lambert HP; Broughton ES; Baker CC. (Mar 1988). Failure of penicillin prophylaxis in laboratory acquired leptospirosis. Postgrad Med J. 64:236-238.
  • Gilks CF. (23 Jan 1988). Cycads and sago. Lancet. 1:181-182.
  • Peto TE; Gilks CF. (31 May 1986). Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis. Lancet. 1:1256-1261.
  • Grundy A; Gilks CF. (Apr 1984). Typhoid: an unusual cause of gastro-intestinal bleeding. Br J Radiol. 57:344-346.

Conferences

  • Phillips A; Pillay D; Miners A; Bennett D; Gilks CF; Lundgren JD. Predicting the effects on resistance of lack of viral load monitoring in resource-limited settings. 17th International HIV Drug Resistance Workshop. 13:A159-A159. (2008).
  • Gilks CF. HIV and pneumococcal infection in Africa - Clinical, epidemiological and preventative aspects. 91:627-631. (Nov 1997).
  • Marsh BJ; vonReyn CF; Edwards J; Ristola MA; Bartholomew C; Brindle RJ; Gilks CF; Waddell R; et alTosteson ANA; Pelz R; Sox CH; Frothingham R; Arbeit RD; Jacobs NJ; Maslow J; Lahdevirta J; Buhler S; Ruohonen R; Lumio J; Ranki A; Vuento R; Prabhakar P; Magnusson M. The risks and benefits of childhood bacille Calmette-Guerin immunization among adults with AIDS. 11:669-672. (Apr 1997).
  • Gilks CF. Tuberculosis and HIV infection. 44:14-16. (Jan 1996).
  • GILKS CF. PROPHYLAXIS FOR HIV-ASSOCIATED INFECTIONS IN THE DEVELOPING-WORLD. MEETING ON PROPHYLAXIS AT THE MARGINS. 31:119-128. (Feb 1993).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook